
Jason A Bond
Articles
-
1 week ago |
ragingbull.com | Jason A Bond
In a move that has sent shockwaves through the biotechnology sector, the U.S. Food and Drug Administration (FDA) announced yesterday its plan to replace animal testing with “more effective, human-relevant methods,” including artificial intelligence (AI) models in drug development. And one stock is leading the charge: Recursion Pharmaceuticals Inc. (NASDAQ: RXRX). Shares of Recursion Pharmaceuticals […]
-
Jan 13, 2025 |
ragingbull.com | Jeff Bishop |Jason A Bond
Folks, we’ve got a real barnburner on our hands today! Intra-Cellular Therapies Inc (ITCI) is making waves in the healthcare sector with an astonishing 34.20% gain. But what’s driving this explosive move? Let me tell you, it’s not just any ordinary stock. ITCI has been a darling of Wall Street for years, and today’s surge only adds fuel to the fire. So, who is ITCI?
-
Jan 10, 2025 |
ragingbull.com | Jeff Bishop |Jason A Bond
Folks, I’ve got my eyes on a stock that’s making some serious noise in the market today. We’re talking about Walgreens Boots Alliance Inc., WBA, and it’s up by an impressive 25.9% so far this morning. Now, before we dive into the details, let me tell you – I’m not here to make any buy or sell recommendations. My goal is to give you a balanced view of what’s happening in the market.
-
Jan 10, 2025 |
ragingbull.com | Jeff Bishop |Jason A Bond
Good day, 360! Happy Friday!Here are some of our top movers today.
-
Jan 9, 2025 |
ragingbull.com | Jason A Bond |Jeff Bishop
Good morning,With the markets closed today, I wanted to share 7 things that, when I do them, I often lose money fast. By keeping this list in front of me daily, I’m less likely to slip into bad habits, and more likely to grow my account. #1 — Trading without a blueprint:Options or stocks? Long or short? Portfolio allocation? Profit goal and stop loss? Fundamentals or technical analysis? All of these must be decided and defined before placing a trade.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →